In Phase A, individuals will get various doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. Supplemental participants might be enrolled at the recognized monotherapy dosign regimen. In Section B, contributors will receive oral ruxolitinib and ABBV-744 will likely be specified as "add-on" therapy. In Segment C, https://penny222pal6.hyperionwiki.com/user